Evaluation of molecular markers to predict the pattern of tumor recurrence and prognosis in pancreatric ductal adenocarcinoma

Evaluation of molecular markers to predict the pattern of tumor recurrence and prognosis in pancreatric ductal adenocarcinoma - PANCALYZE

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00006179

Enrollment

600

Registered

2014-05-20

Start date

2014-05-11

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C25

Interventions

Group 1: Construction of a central biobank (tissue samples, blood samples), analysis of molecular markers, correlation with the clinical course of the disease

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Suspected pancreatic carcinoma, intention to perfom curative surgery

Exclusion criteria

Exclusion criteria: Patient is inoperable No tumor samples can be taken No ductal adenocarcinomain the final histology Overall survival less than 30 days

Design outcomes

Primary

Measure	Time frame
correlation of biomarker expression and clinical course	—

Secondary

Measure	Time frame
Overall survival	—

Countries

Germany

Contacts

Public ContactLara Marks

Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax- und Transplantationschirurgie

lara.marks@uk-koeln.de022147897044

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026